We describe a case of pneumonia and empyema thoracis caused by trimethoprim e sulfamethoxazole-susceptible, but imipenem-resistant Nocardia abscessus in a cancer patient. The isolate was confirmed to the species level by 16S rRNA sequencing analysis. The patient did not respond to antibiotic therapy, including ceftriaxone and imipenem, and died of progressing pneumonia and multiple organ failure.
Introduction
The incidence of local and disseminated infections due to Nocardia species is increasing, especially in immunocompromised individuals. 1e4 The most common risk factors for acquiring Nocardia infections include long-term steroid usage, neoplastic disease, and human immunodeficiency virus infection. 4e6 Advanced molecular methods such as polymerase chain reaction restriction enzyme analysis and 16S rRNA sequencing have resulted in the identification of a number of new species of the genus Nocardia in recent years. 1 Clinically, accurate identification of isolates beyond the genus level is essential because strains of Nocardia species can differ in the clinical presentations of nocardiosis and in resistance patterns to antibiotics. 4, 7 N. abscessus was first proposed as a new species by Yassin et al in 2001 8 ; however, little is known about its clinical significance. We describe a case of empyema thoracis due to N. abscessus in a cancer patient.
Case report
A 54-year-old man had a medical history of angiosarcoma status after five courses of doxorubicin, and undergoing chemotherapy with paciltaxel. Six months prior to admission, he received video-assisted thoracoscopic surgery for diagnosis of a right middle lobe mass, which was proved to be metastatic angiosarcoma. The patient presented to the hospital with a 1-week history of mild respiratory distress, chest pain, fever, and purulent discharge from the videoassisted thoracoscopic surgery incision site on the right lower chest wall.
Physical examination revealed a body temperature of 38. 6 C, a pulse rate of 112/min, a respiratory rate of 25/ min, and a blood pressure of 125/73 mmHg. Coarse crackles were heard in both lung fields, but were more prominent in the right lower lung. Laboratory studies disclosed the following values: white blood cell count, 16.49 Â 10 9 /L with neutrophil predominance (92%); serum urea nitrogen, 190 mg/L; serum creatinine, 5.8 mg/L; alanine aminotransferase, 18 U/L; sodium, 130 mM; and C-reactive protein, 93 mg/L (reference value, <8.0 mg/L). Chest radiography showed multiple nodules and patchy infiltrations in both lungs, although they were more obvious at the base of the right lung (Fig. 1A) .
Ceftriaxone was administered after collecting pus and sputum cultures. Because of the poor condition of the wound, the wound was debrided and a chest tube was inserted for drainage of pleural effusion that was detected by chest sonography. A diagnosis of empyema thoracis was made based on demonstration of frank pus upon pleural fluid aspiration. The clinical condition of the patient, however, gradually deteriorated and eventually resulted in acute respiratory failure with shock. The patient was intubated because of hypoxemic respiratory failure and admitted to the intensive care unit.
Microbiological staining of the pus and pleural fluid specimens both disclosed Gram-positive branching bacilli and acid-fast bacilli (by modified acid-fast stain). Cultures of sputum, pus, and pleural effusion cultures all grew Gram-positive bacilli with beaded branching filaments and weakly acid-fast rods after incubation for 3 days, suggesting the presence of Nocardia species. In addition, the isolates were unable to hydrolyze casein, xanthine, hypoxanthine, or tyrosine. Ceftriaxone was switched to imipenem/cilastatin to expand the coverage of probably concurrently encountered nosocomial copathogens and Nocardia spp. However, the patient's condition continued to deteriorate. Follow-up of chest radiography revealed progressive patchy infiltrations bilaterally (Fig. 1B) . The patient demonstrated symptoms and signs of multiple organ failure and died on the 20th hospitalization day.
The isolate was confirmed to be N. abscessus [GenBank accession number GU471235.1; maximal identity, 100% (564/ 564)] by 16S rRNA gene sequence analysis as reported previously. 4, 7 The minimum inhibitory concentration (MIC) was 4.0 mg/L for trimethoprimesulfamethoxazole, >32 mg/L for both ciprofloxacin and imipenem, and 1.5 mg/L for ceftriaxone as determined by the E-test (AB Biodisk, Solna, Sweden).
Discussion
The clinical manifestations of infections caused by N. abscessus include respiratory tract infection, primary cutaneous infection, pericarditis, cerebral abscess, ocular infection, and disseminated infection. 2,9e16 In a previously reported multicenter study of the clinical presentations of infections due to various Nocardia species during a 13-year period in Taiwan, 4 one case of N. abscessus-related brain abscess was identified. In the present report, we used conventional biochemical studies and molecular methods to Nocardia abscessus in a cancer patientconfirm that the empyema thoracis and pulmonary infection in our patient were due to N. abscessus.
Previous studies have demonstrated that patients with human immunodeficiency virus infection, those on corticosteroid therapy, patients with chronic obstructive pulmonary diseases, systemic lupus erythematosus, rheumatoid arthritis, or lung cancer are at increased risk for developing infections due to N. abscessus. 2, 11, 12 In our patient, the condition of angiosarcoma and chemotherapy was considered the main predisposing factor for N. abscessus infection.
We previously reported that trimethoprimesulfamethoxazole had good in vitro activity against the most common clinical isolates of Nocardia species, such as Nocardia brasiliensis, but that its activity against other Nocardia species varied. 7 We also found that three N. abscessus isolates were susceptible to sulfamethoxazole, imipenem, ceftriaxone, and amikacin. 7 By contrast, a study conducted in Spain showed that all six of the clinical isolates of N. abscessus analyzed were resistant to imipenem with MIC values !32 mg/m.
2 In addition, a study conducted in India reported that two clinical isolates of N. abscessus were susceptible to amikacin and tobramycin but that they showed different resistance patterns against azithromycin, clarithromycin, ciprofloxacin, and gatifloxacin. 15 In the present study, we found that N. abscessus isolates were susceptible to trimethoprimesulfamethoxazole and ceftriaxone but resistant to imipenem (MIC >32 mg/mL) that was administered in our patient. Overall, no solid conclusion on the susceptibility profiles of N. abscessus can be drawn based on the limited number of in vitro studies. The lack of use of trimethoprimesulfamethoxazole that was active against the N. abscessus isolate might partly contribute to the treatment failure of this patient. Further large-scale studies are needed to evaluate the antibiotic resistance pattern of N. abscessus.
In conclusion, we have described a fatal case of pneumonia and empyema thoracis caused by trimethoprimesulfamethoxazole-susceptible, but imipenemresistant N. abscessus in a cancer patient. Sequencing of the 16S rRNA gene is essential for the identification of bacteria in the Nocardia genus to the species level.
